Heather L. Sloan

T-Cell Therapy Using Interleukin-21–Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression

Aude G. Chapuis, Ilana M. Roberts, John A. Thompson et al. · Journal of Clinical Oncology · 2016 · 116 citations · Full text

Life Sciences, Immunology, Oncology +17

Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I

Aude G. Chapuis, Olga K. Afanasiev, Jayasri G. Iyer et al. · Cancer Immunology Research · 2013 · 97 citations

Life Sciences, Immunology, Oncology +17

Combined IL-21–primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient

Aude G. Chapuis, Sylvia M. Lee, John A. Thompson et al. · The Journal of Experimental Medicine · 2016 · 82 citations · Full text

Life Sciences, Immunology, Oncology +17

IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy

Karan Kohli, Yao Lu, Theodore S. Nowicki et al. · Journal for ImmunoTherapy of Cancer · 2021 · 19 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients

Saul E. Rivkin, James Moon, Desiree Iriarte et al. · International Journal of Gynecological Cancer · 2019 · 17 citations

Medicine, Oncology, Pharmacology +17